Crizotinib In Advanced Alk-Positive Non-Small Cell Lung Cancer: Results Of A Retrospective Cohort In Complejo Hospitalario De Navarra, Spain.

Berta Hernandez,Maite Martinez,Lucia Teijeira,David Guerrero,Elena Mata, Irene Gil,Ainhoa Castillo,Juan Verdun, Jose Antonio Rivadeneira,Patricia Ochoa,Esther Aznarez,Idoia Morilla,Susana De La Cruz,Irene Hernandez,Maria Jose Lecumberri,Antonio Viudez,Ruth Vera

JOURNAL OF CLINICAL ONCOLOGY（2014）

引用 2|浏览24

暂无评分

摘要

e19158 Background: Crizotinib is an oral tyrosine kinase inhibitor that targets anaplastic lymphoma kinase (ALK) and has been approved in several countries for treatment of advanced ALK-positive no...

查看译文

关键词

cell lung cancer,crizotinib,alk-positive,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要